Cognitive impairment in spinocerebellar degeneration

European Neurology

Volumn 61, Issue 5, 2009, Pages 257-268

  Kawai, Y ^a   Suenaga, M ^a   Watanabe, H ^a   Sobue, G ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cognitive impairment; Neuropsychological assessment; Spinocerebellar degenerations

Indexed keywords

CLINICAL FEATURE; COGNITIVE DEFECT; DENTATORUBROPALLIDOLUYSIAN ATROPHY; FRIEDREICH ATAXIA; FRONTAL LOBE; HUMAN; MACHADO JOSEPH DISEASE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SHY DRAGER SYNDROME; SPINOCEREBELLAR DEGENERATION;

BRAIN; COGNITION DISORDERS; FRIEDREICH ATAXIA; HUMANS; MULTIPLE SYSTEM ATROPHY; SPINOCEREBELLAR ATAXIAS; SPINOCEREBELLAR DEGENERATIONS;

EID: 62849115056     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000206850     Document Type: Review

References (124)

1. Gilman S, Quinn NP: The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy. Neurology 1996;46:1197-1199.
2. Fogel BL, Perlman S: Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol 2007;6:245-257.
3. Schöls L, Bauer P, Schmidt T, Schulte T, Riess O: Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
4. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, Weber C, Mandel JL, Cancel G, Abbas N, Dürr A, Didierjean O, Stevanin G, Agid Y, Brice A: Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996;14:285-291.
5. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, et al: CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994;8:221-228.
6. Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LP, Zoghbi HY: Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
7. Zhucheko O, Bailey J, Bonnen P, et al: Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997;15:62-69.
8. Schmahmann JD, Sherman JC: The cerebellar cognitive affective syndrome. Brain 1998;121:561-579.
9. Kish SJ, el-Awar M, Schut L, Leach L, Oscar-Berman M, Freedman M: Cognitive deficits in olivopontocerebellar atrophy: Implications for the cholinergic hypothesis of Alzheimer's dementia. Ann Neurol 1988;24:200-206.
10. Tang B, Liu C, Shen L, Dai H, Pan Q, Jing L, Ouyang S, Xia J: Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol 2000;57:540-544.
11. Bürk K, Bösch S, Globas C, et al: Executive dysfunction in spinocerebellar ataxia type 1. Eur Neurol 2001;46:43-48.
12. Bürk K, Globas C, Bösch S, Klockgether T, Zühlke C, Daum I, Dichgans J: Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 2003;250:207-211.
13. McMurtray AM, Clark DG, Flood MK, Perlman S, Mendez MF: Depressive and memory symptoms as presenting features of spinocerebellar ataxia. J Neuropsychiatry Clin Neurosci 2006;18:420-422.
14. Genis D, Matilla T, Volpini V, Rosell J, Dávalos A, Ferrer I, Molins A, Estivill X: Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology 1995;45:24-30.
15. Gilman S, Sima AA, Junck L, Kluin KJ, Koeppen RA, Lohman ME, Little R: Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 1996;39:241-255.
16. Dürr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J, Bellance R, Buisson GG, Chneiweiss H, Dellanave J, et al: Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 1995;118:1573-1581.
17. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM: The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 1997;60:842-850.
18. Schöls L, Amoiridis G, Büttner T, Przuntek H, Epplen JT, Riess O: Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol 1997;42:924-932.
19. Moretti P, Blazo M, Garcia L, Armstrong D, Lewis RA, Roa B, Scaglia F: Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy. Am J Med Genet A 2004;124:392-396.
20. Velázquez-Pérez L, Fernandez-Ruiz J, Díaz R, González RP, Ochoa NC, Cruz GS, Mederos LE, Góngora EM, Hudson R, Drucker-Colin R: Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol 2006;253:1165-1169.
21. Bürk K, Globas C, Bösch S, et al: Cognitive deficits in spinocerebellar ataxia 2. Brain 1999;122:769-777.
22. Le Pira F, Zappalà G, Saponara R, et al: Cognitive findings in spinocerebellar ataxia type 2: relationship to genetic and clinical variables. J Neurol Sci 2002;201:53-57.
23. Fernandez-Ruiz J, Velásquez-Perez L, Díaz R, Drucker-Colín R, Pérez-González R, Canales N, Sánchez-Cruz G, Martínez-Góngora E, Medrano Y, Almaguer-Mederos L, Seifried C, Auburger G: Prism adaptation in spinocerebellar ataxia type 2. Neuropsychologia 2007;45:2692-2698.
24. Boesch SM, Donnemiller E, Müller J, Seppi K, Weirich-Schwaiger H, Poewe W, Wenning GK: Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study. Mov Disord 2004;19:1320-1325.
25. Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC: Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2. Mov Disord 2002;17:1046-1051.
26. Varrone A, Salvatore E, De Michele G, Barone P, Sansone V, Pellecchia MT, Castaldo I, Coppola G, Brunetti A, Salvatore M, Pappatà S, Filla A: Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism. Ann Neurol 2004;55:426-430.
27. Wüllner U, Reimold M, Abele M, Bürk K, Minnerop M, Dohmen BM, Machulla HJ, Bares R, Klockgether T: Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch Neurol 2005;62:1280-1285.
28. Furtado S, Farrer M, Tsuboi Y, Klimek ML, de la Fuente-Fernández R, Hussey J, Lockhart P, Calne DB, Suchowersky O, Stoessl AJ, Wszolek ZK: SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. Neurology 2002;59:1625-1627.
29. Brenneis C, Bösch SM, Schocke M, Wenning GK, Poewe W: Atrophy pattern in SCA2 determined by voxel-based morphometry. Neuroreport 2003;14:1799-1802.
30. Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G: Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol 1999;97:306-310.
31. Løkkegaard T, Nielsen JE, Hasholt L, Fenger K, Werdelin L, Tranebjaerg L, Lauritzen M, Colding-Jørgensen E, Grønbech-Jensen M, Henriksen OA, Sørensen SA: Machado-Joseph disease in three Scandinavian families. J Neurol Sci 1998;156:152-157.
32. Fukutake T, Shinotoh H, Nishino H, Ichikawa Y, Goto J, Kanazawa I, Hattori T: Homozygous Machado-Joseph disease presenting as REM sleep behaviour disorder and prominent psychiatric symptoms. Eur J Neurol 2002;9:97-100.
33. Ishikawa A, Yamada M, Makino K, Aida I, Idezuka J, Ikeuchi T, Soma Y, Takahashi H, Tsuji S: Dementia and delirium in 4 patients with Machado-Joseph disease. Arch Neurol 2002;59:1804-1808.
34. Maruff P, Tyler P, Burt T, Currie B, Burns C, Currie J: Cognitive deficits in Machado-Joseph disease. Ann Neurol 1996;40:421-427.
35. Zawacki TM, Grace J, Friedman JH, Sudarsky L: Executive and emotional dysfunction in Machado-Joseph disease. Mov Disord 2002;17:1004-1010.
36. Kawai Y, Takeda A, Abe Y, Washimi Y, Tanaka F, Sobue G: Cognitive impairments in Machado-Joseph disease. Arch Neurol 2004;61:1757-1760.
37. Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, Chneiweiss H, Benomar A, Lyon-Caen O, Julien J, Serdaru M, Penet C, Agid Y, Brice A: Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996;39:490-499.
38. Garrard P, Martin NH, Giunti P, Cipolotti L: Cognitive and social cognitive functioning in spinocerebellar ataxia: a preliminary characterization. J Neurol 2008;255:398-405.
39. Rüb U, de Vos RA, Schultz C, Brunt ER, Paulson H, Braak H: Spinocerebellar ataxia type 3 (Machado-Joseph disease): severe destruction of the lateral reticular nucleus. Brain 2002;125:2115-2124.
40. Yamada M, Hayashi S, Tsuji S, Takahashi H: Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease. Acta Neuropathol 2001;101:140-144.
41. Taniwaki T, Sakai T, Kobayashi T, Kuwabara Y, Otsuka M, Ichiya Y, Masuda K, Goto I: Positron emission tomography (PET) in Machado-Joseph disease. J Neurol Sci 1997;145:63-67.
42. Soong B, Cheng C, Liu R, Shan D: Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds. Ann Neurol 1997;41:446-452.
43. Etchebehere EC, Cendes F, Lopes-Cendes I, Pereira JA, Lima MC, Sansana CR, Silva CA, Camargo MF, Santos AO, Ramos CD, Camargo EE: Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease. Arch Neurol 2001;58:1257-1263.
44. Murata Y, Yamaguchi S, Kawakami H, Imon Y, Maruyama H, Sakai T, Kazuta T, Ohtake T, Nishimura M, Saida T, Chiba S, Oh-i T, Nakamura S: Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol 1998;55:33-37.
45. Yen TC, Lu CS, Tzen KY, Wey SP, Chou YH, Weng YH, Kao PF, Ting G: Decreased dopamine transporter binding in Machado-Joseph disease. J Nucl Med 2000;41:994-998.
46. Shinotoh H, Thiessen B, Snow BJ, Hashimoto S, MacLeod P, Silveira I, Rouleau GA, Schulzer M, Calne DB: Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease. Neurology 1997;49:1133-1136.
47. Ikeuchi T, Takano H, Koide R, Horikawa Y, Honma Y, Onishi Y, Igarashi S, Tanaka H, Nakao N, Sahashi K, Tsukagoshi H, Inoue K, Takahashi H, Tsuji S: Spinocerebellar ataxia type 6: CAG repeat expansion in alpha1A voltage-dependent calcium channel gene and clinical variations in Japanese population. Ann Neurol 1997;42:879-884.
48. Lee WY, Jin DK, Oh MR, Lee JE, Song SM, Lee EA, Kim GM, Chung JS, Lee KH: Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol 2003;60:858-863.
49. Matsumura R, Futamura N, Fujimoto Y, Yanagimoto S, Horikawa H, Suzumura A, Takayanagi T: Spinocerebellar ataxia type 6: molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion. Neurology 1997;49:1238-1243.
50. Globas C, Bösch S, Zühlke Ch, Daum I, Dichgans J, Bürk K: The cerebellum and cognition: intellectual function in spinocerebellar ataxia type 6 (SCA6). J Neurol 2003;250:1482-1487.
51. Suenaga M, Kawai Y, Watanabe H, Atsuta N, Ito M, Tanaka F, Katsuno M, Fukatsu H, Naganawa S, Sobue G: Cognitive impairment in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatry 2008;79:496-499.
52. Gomez CM, Thompson RM, Gammack JT, Perlman SL, Dobyns WB, Truwit CL, Zee DS, Clark HB, Anderson JH: Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 1997;42:933-950.
53. Sasaki H, Kojima H, Yabe I, Tashiro K, Hamada T, Sawa H, Hiraga H, Nagashima K: Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6). Acta Neuropathol (Berl) 1998;95:199-204.
54. Takahashi H, Ikeuchi T, Honma Y, Hayashi S, Tsuji S: Autosomal dominant cerebellar ataxia (SCA6): clinical, genetic and neuropathological study in a family. Acta Neuropathol (Berl) 1998;95:333-337.
55. Soong B, Liu R, Wu L, Lu Y, Lee H: Metabolic characterization of spinocerebellar ataxia type 6. Arch Neurol 2001;58:300-304.
56. Honjo K, Ohshita T, Kawakami H, Naka H, Imon Y, Maruyama H, Mimori Y, Matsumoto M: Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6. Arch Neurol 2004;61:933-937.
57. Kawai Y, Suenaga M, Watanabe H, Ito M, Kato K, Kato T, Ito K, Tanaka F, Sobue G: Prefrontal hypoperfusion and cognitive dysfunction correlates in spinocerebellar ataxia type 6. J Neurol Sci 2008;271:68-74.
58. Wang PS, Liu RS, Yang BH, Soong BW: Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6: a voxel-based FDG-positron emission tomography analysis. J Neurol 2007;254:838-845.
59. Ikeuchi T, Onodera O, Oyake M, Koide R, Tanaka H, Tsuji S: Dentatorubral-pallidoluysian atrophy (DRPLA): close correlation of CAG repeat expansions with the wide spectrum of clinical presentations and prominent anticipation. Semin Cell Biol 1995;6:37-44.
60. Takahashi H, Ohama E, Naito H, Takeda S, Nakashima S, Makifuchi T, Ikuta F: Hereditary dentatorubral-pallidoluysian atrophy: clinical and pathologic variants in a family. Neurology 1988;38:1065-1070.
61. Muñoz E, Campdelacreu J, Ferrer I, Rey MJ, Cardozo A, Gómez B, Tolosa E: Severe cerebral white matter involvement in a case of dentatorubropallidoluysian atrophy studied at autopsy. Arch Neurol 2004;61:946-949.
62. Koide R, Onodera O, Ikeuchi T, Kondo R, Tanaka H, Tokiguchi S, Tomoda A, Miike T, Isa F, Beppu H, Shimizu N, Watanabe Y, Horikawa Y, Shimohata T, Hirota K, Ishikawa A, Tsuji S: Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy: influence of CAG repeat size on MRI findings. Neurology 1997;49:1605-1612.
63. Tsuchiya K, Oyanagi S, Arima K, Ikeda K, Akashi T, Ando S, Kurosawa T, Ikeuchi T, Tsuji S: Dentatorubropallidoluysian atrophy: clinicopathological study of dementia and involvement of the nucleus basalis of Meynert in seven autopsy cases. Acta Neuropathol 1998;96:502-508.
64. Yamada M, Wood JD, Shimohata T, Hayashi S, Tsuji S, Ross CA, Takahashi H: Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Ann Neurol 2001;49:14-23.
65. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, Ikeda S, Tsuji S, Kanazawa I: SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001;10:1441-1448.
66. De Michele G, Maltecca F, Carella M, Volpe G, Orio M, De Falco A, Gombia S, Servadio A, Casari G, Filla A, Bruni A: Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17. Neurol Sci 2003;24:166-167.
67. Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, Schöls L, Riess O: Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 2003;54:367-375.
68. Schneider SA, van de Warrenburg BP, Hughes TD, Davis M, Sweeney M, Wood N, Quinn NP, Bhatia KP: Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family. Neurology 2006;67:1701-1703.
69. Toyoshima Y, Yamada M, Onodera O, Shimohata M, Inenaga C, Fujita N, Morita M, Tsuji S, Takahashi H: SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol 2004;55:281-286.
70. Bruni AC, Takahashi-Fujigasaki J, Maltecca F, Foncin JF, Servadio A, Casari G, D'Adamo P, Maletta R, Curcio SA, De Michele G, Filla A, El Hachimi KH, Duyckaerts C: Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch Neurol 2004;61:1314-1320.
71. Günther P, Storch A, Schwarz J, Sabri O, Steinbach P, Wagner A, Hesse S: Basal ganglia involvement of a patient with SCA 17: a new form of autosomal dominant spinocerebellar ataxia. J Neurol 2004;251:896-897.
72. Minnerop M, Joe A, Lutz M, Bauer P, Urbach H, Helmstaedter C, Reinhardt M, Klockgether T, Wüllner U: Putamen dopamine transporter and glucose metabolism are reduced in SCA17. Ann Neurol 2005;58:490-491.
73. Lasek K, Lencer R, Gaser C, Hagenah J, Walter U, Wolters A, Kock N, Steinlechner S, Nagel M, Zühlke C, Nitschke MF, Brockmann K, Klein C, Rolfs A, Binkofski F: Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain 2006;129:2341-2352.
74. White M, Lalonde R, Botez-Marquard T: Neuropsychologic and neuropsychiatric characteristics of patients with Friedreich's ataxia. Acta Neurol Scand 2000;102:222-226.
75. Mantovan MC, Martinuzzi A, Squarzanti F, Bolla A, Silvestri I, Liessi G, Macchi C, Ruzza G, Trevisan CP, Angelini C: Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study. Eur J Neurol 2006;13:827-835.
76. de Nobrega E, Nieto A, Barroso J, Monton F: Differential impairment in semantic, phonemic, and action fluency performance in Friedreich's ataxia: possible evidence of prefrontal dysfunction. J Int Neuropsychol Soc 2007;13:944-952.
77. Bürk K: Cognition in hereditary ataxia. Cerebellum 2007;6:280-286.
78. Graham JG, Oppenheimer DR: Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
79. Quinn N: Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;52:78-89.
80. Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, Aiba I, Abe Y, Tamakoshi A, Doyu M, Hirayama M, Sobue G: Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002;125:1070-1083.
81. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK: Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
82. Dujardin K, Defebvre L, Krystkowiak P, Degreef JF, Destee A: Executive function differences in multiple system atrophy and Parkinson's disease. Parkinsonism Relat Disord 2003;9:205-211.
83. Meco G, Gasparini M, Doricchi F: Attentional functions in multiple system atrophy and Parkinson's disease. J Neurol Neurosurg Psychiatry 1996;60:393-398.
84. Pillon B, Gouider-Khouja N, Deweer B, Vidailhet M, Malapani C, Dubois B, Agid Y: Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995;58:174-179.
85. Robbins TW, James M, Lange KW, Owen AM, Quinn NP, Marsden CD: Cognitive performance in multiple system atrophy. Brain 1992;115:271-291.
86. Robbins TW, James M, Owen AM, Lange KW, Lees AJ, Leigh PN, Marsden CD, Quinn NP, Summers BA: Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994;57:79-88.
87. Soliveri P, Monza D, Paridi D, Carella F, Genitrini S, Testa D, Girotti F: Neuropsychological follow-up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2000;69:313-318.
88. Testa D, Fetoni V, Soliveri P, Musicco M, Palazzini E, Girotti F: Cognitive and motor performance in multiple system atrophy and Parkinson's disease compared. Neuropsychologia 1993;31:207-210.
89. Testa D, Filippini G, Farinotti M, Palazzini E, Caraceni T: Survival in multiple system atrophy: a study of prognostic factors in 59 cases. J Neurol 1996;243:401-404.
90. Wenning GK, Ben Shlomo Y, Magalhães M, Daniel SE, Quinn NP: Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-845.
91. Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD: Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain 1997;120:75-90.
92. Monza D, Soliveri P, Radice D, Fetoni V, Testa D, Caffarra P, Caraceni T, Girotti F: Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes. Arch Neurol 1998;55:372-378.
93. Ozsancak C, Auzou P, Dujardin K, Quinn N, Destée A: Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease. J Neurol 2004;251:1317-1323.
94. Benrud-Larson LM, Sandroni P, Schrag A, Low PA: Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord 2005;20:951-957.
95. Fetoni V, Soliveri P, Monza D, Testa D, Girotti F: Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy. J Neurol Neurosurg Psychiatry 1999;66:541-514.
96. Pilo L, Ring H, Quinn N, Trimble M: Depression in multiple system atrophy and in idiopathic Parkinson's disease: a pilot comparative study. Biol Psychiatry 1996;39:803-807.
97. Lange KW, Tucha O, Alders GL, Preier M, Csoti I, Merz B, Mark G, Herting B, Fornadi F, Reichmann H, Vieregge P, Reiners K, Becker G, Naumann M: Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm 2003;110:983-995.
98. Bürk K, Daum I, Rüb U: Cognitive function in multiple system atrophy of the cerebellar type. Mov Disord 2006;21:772-776.
99. Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F, Kato K, Fukatsu H, Naganawa S, Kato T, Ito K, Sobue G: Cognitive impairments in multiple system atrophy: MSA-C vs. MSA-P. Neurology 2008;70:1390-1396.
100. Fujita T, Doi M, Ogata T, Kanazawa I, Mizusawa H: Cerebral cortical pathology of sporadic olivopontocerebellar atrophy. J Neurol Sci 1993;116:41-46.
101. Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, Goto A, Ito Y: Cerebral atrophy in multiple system atrophy by MRI. J Neurol Sci 2000;173:109-112.
102. Konagaya M, Sakai M, Matsuoka Y, Konagaya Y, Hashizume Y: Multiple system atrophy with remarkable frontal lobe atrophy. Acta Neuropathol 1999;97:423-428.
103. Konagaya M, Konagaya Y, Sakai M, Matsuoka Y, Hashizume Y: Progressive cerebral atrophy in multiple system atrophy. J Neurol Sci 2002;195:123-127.
104. Wakabayashi K, Ikeuchi T, Ishikawa A, Takahashi H: Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter. J Neurol Sci 1998;156:114-117.
105. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP: Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147.
106. Papp MI, Lantos PL: The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-243.
107. Specht K, Minnerop M, Abele M, Reul J, Wüllner U, Klockgether T: In vivo voxel-based morphometry in multiple system atrophy of the cerebellar type. Arch Neurol 2003;60:1431-1435.
108. Brenneis C, Boesch SM, Egger KE, Seppi K, Scherfler C, Schocke M, Wenning GK, Poewe W: Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study. Mov Disord 2006;21:159-165.
109. 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry 2004;75:103-109.
110. Gilman S, Koeppe RA, Junck L, Little R, Kluin KJ, Heumann M, Martorello S, Johanns J: Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography. Ann Neurol 1999;45:769-777.
111. 99mTc-TRODAT-1 imaging of multiple system atrophy. J Nucl Med 2004;45:49-55.
112. Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, Poewe W: Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain 2005;128:1605-1612.
113. 99mTc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 2004;45:933-942.
114. Klein D, Milner B, Zatorre RJ, Meyer E, Evans AC: The neural substrates underlying word generation: a bilingual functional imaging study. Proc Natl Acad Sci USA 1995;92:2899-2903.
115. Petersen SE, Fox PT, Posner MI, Mintum MA, Raichle ME: Positron emission tomographic studies of the processing of single words. J Cogn Neurosci 1989;1:153-170.
116. Desmond JE, Gabrieli JD, Wagner AD, Ginier BL, Glover GH: Lobular patterns of cerebellar activation in verbal working-memory and finger-tapping tasks as revealed by functional MRI. J Neurosci 1997;17:9675-9685.
117. Grasby PM, Frith CD, Friston KJ, Bench C, Frackowiak RS, Dolan RJ: Functional mapping of brain areas implicated in auditory-verbal memory function. Brain 1993;116:1-20.
118. Jenkins IH, Brooks DJ, Nixon PD, Frackowiak RS, Passingham RE: Motor sequence learning: a study with positron emission tomography. J Neurosci 1994;14:3775-3790.
119. Kim SG, Ugurbil K, Strick PL: Activation of a cerebellar output nucleus during cognitive processing. Science 1994;265:949-951.
120. Logan CG, Grafton ST: Functional anatomy of human eyeblink conditioning determined with regional cerebral glucose metabolism and positron-emission tomography. Proc Natl Acad Sci USA 1995;92:7500-7504.
121. Allen G, Buxton RB, Wong EC, Courchesne E: Attentional activation of the cerebellum independent of motor involvement. Science 1997;275:1940-1943.
122. Ryding E, Decety J, Sjoholm H, Sternberg G, Ingvar DH: Motor imagery activates the cerebellum regionally. Brain Res Cogn Brain Res 1993;1:94-99.
123. Gao J-H, Parsons LM, Bower JM, Xiong J, Li J, Fox PT: Cerebellum implicated in sensory acquisition and discrimination rather than motor control. Science 1996;272:545-547.
124. Claeys KG, Orban GA, Dupont P, Sunaert S, Van Hecke P, De Schutter E: Involvement of multiple functionally distinct cerebellar regions in visual discrimination: a human functional imaging study. Neuroimage 2003;20:840-854.